NPM1 and acute myeloid leukemia: Among the four subgroups of AML patients identified by hierarchical clustering analysis, the cluster1 AML patients showed younger age, lower cytogenetics risk, higher frequency of NPM1 mutations and more favourable OS than cluster3 patients.